Shkreli faces contempt over trades

The FTC and seven state attorneys general asked a federal court to hold Martin Shkreli in contempt, alleging he violated his lifetime drug-industry ban by trading pharmaceutical stocks.

Reposted by Timothy D. McBride

Scholar power: 2%

Story's scientific field profile

Law 70%, Business 20%, Economics 10%

Name	Field match	H-index	Scholar power
🎓 Timothy D. McBride	-	23	-

New York Times

Martin Shkreli Violated Lifetime Ban From Drug Industry, U.S. Says

The attorneys general of New York and six other states joined the Federal Trade Commission in accusing the disgraced former pharmaceutical executive of repeatedly violating the ban.

Reposts 2 2d

The Wall Street Journal

FTC, States Ask Court to Hold ‘Pharma Bro’ Shkreli in Contempt for Trading Drug Stocks

Regulators allege the ex-drug executive held more than 60 pharmaceutical stocks despite a court order barring him from the industry.

Reposts 1 2d

Financial Times

FTC says ‘pharma bro’ Martin Shkreli repeatedly violated industry ban

US regulators accuse convicted felon of trading in dozens of pharmaceutical stocks and sharing opinions on social media

Reposts 0 2d

Add to Home Screen

News, ranked by scholars

Shkreli faces contempt over trades

Martin Shkreli Violated Lifetime Ban From Drug Industry, U.S. Says

FTC, States Ask Court to Hold ‘Pharma Bro’ Shkreli in Contempt for Trading Drug Stocks

FTC says ‘pharma bro’ Martin Shkreli repeatedly violated industry ban

Add to Home Screen

News, ranked by scholars

Shkreli faces contempt over trades

Scholar power: 2%

Martin Shkreli Violated Lifetime Ban From Drug Industry, U.S. Says

FTC, States Ask Court to Hold ‘Pharma Bro’ Shkreli in Contempt for Trading Drug Stocks

FTC says ‘pharma bro’ Martin Shkreli repeatedly violated industry ban

Sign in to LightNews

Sign up to start reading

Connect Bluesky

Connect with Bluesky